Alligator Bioscience
1,018 SEK -2,12%2 investorer følger denne virksomhed
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Omsætning
58,11 mio.
EBIT %
-428,46 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
ATORX
Daglig lav / høj pris
1,01 / 1,044
SEK
Markedsværdi
772,65 mio. SEK
Aktieomsætning
611,13 t SEK
Volumen
598 t
Seneste videoer
Finanskalender
Delårsrapport
25.04.2024
Generalforsamling
07.05.2024
Delårsrapport
11.07.2024
Delårsrapport
24.10.2024
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Allegro Investment | 31,2 % | 31,3 % |
Roxette Photo | 8,1 % | 8,1 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Alligator publishes outcome in rights issue
Alligator Bioscience Announces Two Presentations on Mitazalimab and ATOR-4066 at the AACR Annual Meeting 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools